NDC 82922-005 - Truemed Group LLC
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 82922-005
- Package NDCs from labels
- 82922-005-02
- Manufacturer
- Truemed Group LLC
- Effective date
- 2022-08-08
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| METRONIDAZOLE - Truemed Group LLC | Truemed Group LLC | 2022-08-08 | HUMAN PRESCRIPTION DRUG LABEL |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| metronidazole | METRONIDAZOLE | Bryant Ranch Prepack | 9e702861-87f5-4bc0-864d-317050020194 | 2024-08-12 | Boxed warning, Warnings, Adverse reactions | 140QMO216E |
| metronidazole | METRONIDAZOLE | Bryant Ranch Prepack | 1030e723-cde9-44a7-8dab-2f0932ffcc2c | 2024-08-12 | Boxed warning, Warnings, Adverse reactions | 140QMO216E |
| Metronidazole | METRONIDAZOLE | Bryant Ranch Prepack | ea635d05-b3c1-4f49-ace2-d091c20920da | 2024-08-09 | Boxed warning, Warnings, Adverse reactions | 140QMO216E |
| Metronidazole | METRONIDAZOLE | Bryant Ranch Prepack | cdd942a1-fb3b-4912-bd3f-8aef451e6a3c | 2024-08-08 | Boxed warning, Warnings, Adverse reactions | 140QMO216E |
| Metronidazole | METRONIDAZOLE | Unichem Pharmaceuticals (USA), Inc. | 9219588b-0a99-40b9-bdd4-ced6d6efebed | 2024-08-01 | Boxed warning, Warnings, Adverse reactions | 140QMO216E |
| Metronidazole | METRONIDAZOLE | Proficient Rx LP | e313c7d9-fb7b-4d0f-bccf-cc72ac5ef205 | 2024-08-01 | Boxed warning, Warnings, Adverse reactions | 140QMO216E |
| Metronidazole | METRONIDAZOLE | Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc. | d9e33638-3803-426e-a1c3-7d0cf145d92f | 2024-07-22 | Boxed warning, Warnings, Adverse reactions | 140QMO216E |
| Metronidazole | METRONIDAZOLE | NuCare Pharmaceuticals,Inc. | ae2e4bbe-8c12-4af9-e053-2a95a90af299 | 2024-07-17 | Boxed warning, Warnings, Adverse reactions | 140QMO216E |
| Metronidazole | METRONIDAZOLE | NuCare Pharmaceuticals,Inc. | b2bd62c2-c6ed-f459-e053-2a95a90a90eb | 2024-07-17 | Boxed warning, Warnings, Adverse reactions | 140QMO216E |
| Metronidazole | METRONIDAZOLE | Alembic Pharmaceuticals Inc. | b1fcf023-cdfd-45b7-b4d4-ff814f33ee79 | 2024-07-17 | Boxed warning, Warnings, Adverse reactions | 140QMO216E |
| Metronidazole | METRONIDAZOLE | Teva Pharmaceuticals USA, Inc. | 291a45f6-ed27-4dcc-8364-358d08623797 | 2024-07-01 | Boxed warning, Warnings, Adverse reactions | 140QMO216E |
| Metronidazole | METRONIDAZOLE | NuCare Pharmaceuticals,Inc. | 937913b8-c131-6339-e053-2a95a90a4dd9 | 2024-06-19 | Boxed warning, Warnings, Adverse reactions | 140QMO216E |
| Metronidazole | METRONIDAZOLE | A-S Medication Solutions | 9d41a8b3-b8cc-4fb6-9813-d3bfa048ed78 | 2024-05-06 | Warnings, Adverse reactions | 140QMO216E |
| metronidazole | METRONIDAZOLE | Asclemed USA, Inc. | 89970965-a995-4ae4-a70b-bd2de38081e1 | 2024-04-26 | Boxed warning, Warnings, Adverse reactions | 140QMO216E |
| Metronidazole | METRONIDAZOLE | Alembic Pharmaceuticals Inc. | 9f56cc00-6383-48c8-95ee-e6a404a0237b | 2024-03-05 | Warnings, Adverse reactions | 140QMO216E |
| Metronidazole | METRONIDAZOLE | Chartwell RX, LLC | f053ad94-d884-457c-9c35-4e0df1d26eea | 2024-02-29 | Boxed warning, Warnings, Adverse reactions | 140QMO216E |
| Metronidazole | METRONIDAZOLE | Bryant Ranch Prepack | 38376be4-4bb3-4647-aedf-bb7bfef053e5 | 2024-02-29 | Adverse reactions | 140QMO216E |
| metronidazole | METRONIDAZOLE | NuCare Pharmaceuticals,Inc. | c2dbfec8-da5b-cd2b-e053-2a95a90ad17c | 2024-02-09 | Boxed warning, Warnings, Adverse reactions | 140QMO216E |
| Metronidazole | METRONIDAZOLE | Cosette Pharmaceuticals, Inc. | de4cb39f-cc6e-98fb-05e5-103f3aca2dad | 2023-11-29 | Adverse reactions | 140QMO216E |
| Nuvessa | METRONIDAZOLE | Exeltis USA, Inc. | 3b6ff39d-f84b-43b3-9b07-c0521c6d7968 | 2023-11-10 | Warnings, Adverse reactions | 140QMO216E |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.